Repost: Alzheimer's disease may be the last straw that

New Post Public Reply Private Reply Replies (2) Message Board
bellsandwhistles
Repost: Alzheimer's disease may be the last straw that propels medical cannabis into the mainstream and denigrates the status and influence of Big Pharma, which offers no treatment of cure for Alzheimer's. Alzheimer's has leaped from far down to  #3 as a cause of death, according to new evidence. "Deaths from Alzheimer's Six Times Higher than Previous Estimate " (Reuters)

MMJ  seems to have the answer.

The baby boomers (born 1946 - 1964) are the largest US demographic (75 million) and fastest-growing age demographic. Alzheimer's disease affects an estimated 1 in 10 people over age 65. It is the most common form of dementia and said to have no cure. New evidence ranks it as a major killer. Heart/vascular disease is #1; cancer is #2; Alzheimer's is now  #3.

It's likely  the baby-boomer bloc, who vote in high numbers and collectively control vast wealth, will not accept the status quo denial of MMJ due to the incoherent and nonsensical federal ban on MMJ/MJ nor tolerate the pawns of Big Pharma and the cartels who stubbornly resist the will of the people.

A)  Dr. Chu Chen of Lousiana State University: " There are no effective medications (i.e., Big Pharma medications) currently available for preventing and treating Alzheimer's disease or halting disease progression.

Scientists have also found that medical cannabis helps to dramatically reduce chronic pain, and reduce tremors and improve mood and communication skills in Alzheimer's sufferers.

Chen and his team found that THC treatment caused an increase in the levels of an enzyme in the hippocampus, a brain region involved in memory and learning.

Chen: "Our results suggest that the unwanted side effects of cannabis could be eliminated or reduced, while retaining its beneficial effects, by administering a COX-2 inhibitor [painkiller] along with THC for the treatment of intractable medical conditions such as Alzheimer's disease."
http://www.ibtimes.co.uk/medical-marijuana-ca...ory-524214
###

Headline: Deaths from Alzheimer's Six Times Higher than Previous Estimate

March 6, 2014. NEW YORK (Reuters Health) - Nearly half a million elderly Americans likely died from Alzheimer's disease in 2010, a figure almost six times higher than previous estimates of annual deaths, according to a new study released on Wednesday.

Dr. James Leverenz of Ohio's Cleveland Clinic Lou Ruvo Center for Brain Health: "The aging of the baby boomer population means more people living with Alzheimer's disease, which in
turn means more people dying from Alzheimer's disease since no effective treatment (i.e., Big Pharma treatments) or cure exists."

A1) Full article
Medical Marijuana 'Holds Promise for Alzheimer's Treatment'
http://www.ibtimes.co.uk/medical-marijuana-ca...ory-524214

Cannabis has been used for medical purposes for centuries for treating a wealth of conditions from chronic pain to epilepsy.

Its use in modern medicine has been stunted because of side effects, however, with the Food and Drugs Administration unwilling to approve of its use.

Researchers with Louisiana State University have found a way to reduce the side effect of memory loss associated with cannabis use and said it could be adapted as a treatment for Alzheimer's.

Scientists found that memory loss from medical marijuana could be prevented with over-the-counter painkillers such as Ibuprofen.

In findings published in the journal Cell, senior author Chu Chen said: "Our studies have solved the long-time mystery of how marijuana causes neuronal and memory impairments. The results suggest that the use of medical marijuana could be broadened if patients concurrently take a non-steroidal anti-inflammatory drug such as Ibuprofen."

The active ingredient in cannabis is tetrahydrocannabinol (THC) and some drugs based on this compound have been approved for medical use to treat nausea, vomiting and chemotherapy patients.
THC

THC destroys cancer cells and helps treat chronic pain sufferers (Reuters)

Previous research has shown that cannabis has a potent anti-cancer agent that destroys cancer cells.

Scientists have also found that medical cannabis helps to dramatically reduce chronic pain, and reduce tremors and improve mood and communication skills in Alzheimer's sufferers.

Chen and his team found that THC treatment caused an increase in the levels of an enzyme in the hippocampus, a brain region involved in memory and learning.

Testing on mice, researchers were able to reduce levels of this enzyme using drugs to stop memory problems and brain abnormalities that normally occur from repeat THC exposure.

Chen said: "There are no effective medications currently available for preventing and treating Alzheimer's disease or halting disease progression.

"Our results suggest that the unwanted side effects of cannabis could be eliminated or reduced, while retaining its beneficial effects, by administering a COX-2 inhibitor [painkiller] along with THC for the treatment of intractable medical conditions such as Alzheimer's disease."

B 1) Full article:
Deaths from Alzheimer's Six Times Higher than Previous Estimate
By Kathryn Doyle
March 6, 2014. NEW YORK (Reuters Health) - Nearly half a million elderly Americans likely died from Alzheimer's disease in 2010, a figure almost six times higher than previous estimates of annual deaths, according to a new study released on Wednesday.

The Centers for Disease Control and Prevention has estimated that approximately 5 million people are living with Alzheimer's disease in the United States, and that 83,000 die from the condition each year.

"Many people do not realize that Alzheimer's is a fatal disease," said lead author Bryan D. James of the Rush Alzheimer's Disease Center in Chicago.

"Alzheimer's disease starts in the part of your brain that controls your memory and thinking, but over years it spreads to the parts of your brain that control more basic functions such as breathing and swallowing," he told Reuters Health in an email.

Current national estimates are based on death certificates, which tend to underestimate deaths from dementia, he and his colleagues write in the journal Neurology.

They analyzed data from two existing studies that followed people age 65 and older, starting at a time when they did not have Alzheimer's. The participants were tracked for an average of eight years, with annual checkups and brain donation in the case of death.

One study followed religious orders of nuns and priests and the other followed people in retirement communities and senior housing facilities. In all, the studies tracked 2,566 people.

Over the course of the two studies, 559 participants developed Alzheimer's disease and 1,090 participants died.

People diagnosed with Alzheimer's were more than three times as likely to die as those without it. The risk was more than four times as high among participants aged 75 to 84.

Applying these figures to U.S. deaths in 2010, when the data in the two studies were collected, the authors estimate that about 500,000 people over age 75 died from Alzheimer's disease that year.

"There's no doubt that if you have Alzheimer's disease, it increases mortality risk," said Dr. James Leverenz of the Cleveland Clinic Lou Ruvo Center for Brain Health in Ohio.

But although current national estimates for Alzheimer's deaths are definitely low, he's not sure the true number is as high as the one found in this study.

"The two groups are pretty highly educated," said Leverenz, who was not involved in the new research. "They were in generally a little bit better health than the general population."

That means people in these studies could have been less likely to die from heart disease or other conditions, so a higher proportion might have died from Alzheimer's, he explained.

One of the reasons it is so hard to estimate the number of deaths from Alzheimer's is that dementia can be the underlying reason for a number of more immediate causes of death, Leverenz said. For instance, severe dementia can lead to problems swallowing, which leads to malnutrition, which can lead to pneumonia, the study authors write.

Death certificates tend to list the immediate cause of death, in this case pneumonia, and leave out dementia.

"Understanding that AD may contribute to almost as many deaths as the two leading killers in America, heart disease and cancer, is an eye-opening figure that may convince the public and policy makers that AD funding should be increased," James said.

In the study, participants lived an average of four years after an Alzheimer's diagnosis, but Leverenz said he has seen patients live with the condition for much longer - 10 or even 20 years for those with an earlier onset of disease.

"The aging of the baby boomer population means more people living with Alzheimer's disease, which in turn means more people dying from Alzheimer's disease since no effective treatment or cure exists," James said.

http://investorshangout.com/boards/message?id=1291767

SK3 Group Inc. (SKTO) Stock Research Links

SKTO Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Historic Records Set at 2026 CNO Monumental Marathon

Updated Category News Views 530

Race to Remember: Monumental Breakthroughs In the chilly November air of Indianapolis, the 2026 CNO Financial Indianapolis Monumental Marathon wasn't just another tick on the calendar—this was a banner day for running. With record-breaking performances across every distance, we saw what happens when a community of athletes, sponsors, and volunteers hits a perfect...

Continue Reading
D-Wave's Legal Trouble: Securities Fraud Suit Looms

Updated Category News Views 145

A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...

Continue Reading
MWC26 Doha: Bridging Standards for MENA's Future

Updated Category News Views 271

MWC26 Doha Launches with a Connectivity Mission Forget corporate boardrooms; the real action this week is unfolding in Doha's bustling exhibition halls. Kicked off with the fanfare you'd expect from such a key event, MWC26 Doha has drawn a crowd that's got both tech geeks and policy wonks nodding with interest. This ain’t your average trade show: it’s the melting pot...

Continue Reading
TCL's Display Future: AI Meets Screens at DTC 2026

Updated Category News Views 518

Exploring New Horizons in Display Technology There's something brewing in Wuhan: a conference that’s shaping up like a tech enthusiast’s dream. This year, it's all about the symbiosis of cutting-edge tech and dazzling visuals as TCL CSOT gears up to unveil advancements at the Global Display Tech-Ecosystem Conference (DTC) 2026. If you're wondering whether this event...

Continue Reading
Cleaner Air in Bedroom May Stabilize Blood Sugar Levels

Updated Category News Views 206

Imagine a world where simply sleeping in cleaner air could affect your blood sugar. Seems far-fetched, I know. But that's where we're at with this new study out of NYU Langone Health. They're talking about using plain ol' portable air filters to help steady blood sugar levels for folks dealing with prediabetes. Turns out a cleaner bedroom might just hold the key to taming...

Continue Reading
Amplifon Data Breach Spurs Legal Scrutiny for Millions

Updated Category News Views 175

Data Breach Fallout: Amplifon Under Fire When a big player like Amplifon gets hit with a data breach, it's like a wake-up call across the board. This one’s no small spill—over 1.3 million folks left wondering whether their personal information is fluttering around cyberspace for all who dare to peek. If you’ve missed the memo, Edelson Lechtzin LLP, the savvy cats in...

Continue Reading
Moon Base Ambitions: Impulse Space Wins Key NASA Contracts

Updated Category News Views 630

NASA's Vision and Impulse's New Role Ever think you'd see a company like Impulse Space set to play a starring role in humanity's return to the lunar surface? Well, strap in because this isn't just a pipe dream anymore. NASA's bold plan to establish a Moon Base has taken a tangible step forward with Impulse winning two hefty task orders. This ain't just peanuts—this duo...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 0

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading
Quantum Space Joins $185M NASA Lunar Transport Deal

Updated Category News Views 777

Quantum Space Bags a Chunk of NASA's Lunar Ambitions Alright, folks, buckle up because we're about to dive into the cosmos. Quantum Space just nabbed a sweet deal—a $185 million whopper of a contract from NASA's Moon Base Transportation program. This isn't chump change; it's a 25% slice for Quantum from the lot Arrow Science and Technology is heading. We're talking...

Continue Reading
Boston STEM Expo Sparks Young Minds in Engineering

Updated Category News Views 281

If you really want to light up a kid's imagination, throw them into a room full of science experiments and let 'em have at it. That's exactly what happened at the recent Society of Women Engineers' Innovation Expo in Boston's Seaport District. The place was buzzing, and not just because of all the engineering gadgets on display—it was the energy of young minds...

Continue Reading

Top 5 Most Recently Viewed Articles

Fabuwood Unveils Mocha: A Sophisticated Stain for Modern Cabinets

Updated Category News Views 377

Fabuwood Introduces Mocha: A New Era in Cabinet Stains Fabuwood has delighted the home improvement community with the launch of their newest cabinet stain, Mocha. This inviting, versatile color showcases a beautiful balance of warmth and sophistication. As a highly anticipated addition, Mocha complements the existing range of popular natural stains from Fabuwood,...

Continue Reading
Revolutionizing Home Lighting with AI Technology by Lepro

Updated Category News Views 266

Revolutionizing Home Lighting with AI Technology Lepro, a pioneering company in AI lighting innovation, has introduced an incredible advancement at the Consumer Electronics Show (CES) 2025. The innovative product, LightGPM 3, is designed as an artificial intelligence-driven lighting design assistant that makes professional lighting accessible to everyone. LightGPM 3: Your...

Continue Reading
Insights on Upcoming Bond Listing by Jyske Realkredit A/S

Updated Category News Views 135

Understanding the Bond Listing by Jyske Realkredit A/S On September 5, 2025, an important announcement was issued regarding the final terms for a new bond issuance by Jyske Realkredit A/S aimed at the market, set to be listed soon. Details of the Upcoming Bond Offering This bond, categorized as a Covered Bond (SDO), aims to officially open for transaction on February 10,...

Continue Reading
Smart Meter Market Set for $23.46B Leap by 2031

Updated Category News Views 8

Smart Meters: Electrifying Market Growth Ahead In the fast-evolving world of utilities, the smart electricity meter market is gearing up for a substantial leap, jumping from USD 15.02 billion in 2026 to a remarkable USD 23.46 billion by 2031. A recent study from Mordor Intelligence shines a light on this trajectory, emphasizing a robust compound annual growth rate (CAGR)...

Continue Reading
Bitcoin Struggles to Maintain $100k Amid Fed's Rate Concerns

Updated Category News Views 109

Bitcoin's Recent Price Movements Recently, Bitcoin has experienced notable fluctuations, trading at approximately $95,445.4, following a week filled with substantial declines. Market participants are now more skeptical, assessing the macroeconomic landscape shaped by the Federal Reserve's comments. The Impact of Fed's Hawkish Stance The Federal Reserve's recent...

Continue Reading